Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FE 999913 in Japanese IVF patients
NCT01710514Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Oct 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of progesterone in infertility (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoints: Proportion of Subjects With Blood Progesterone Concentration Not Less Than 10 ng/ml at Day 5 and Ongoing Pregnancy Rate at Week 5. Started Oct 2012; status: completed.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01710514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01710514.